Kathryn Shoemaker

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine”.

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

New England Journal of Medicine(2021)10.1056/nejmoa2105290

N/A

7.5DataRank · unranked

684 citations

Magdalena E. Sobieszczyk, Ian Hirsch, Stephanie Sproule, Merlin L. Robb, Lawrence Corey +40 more

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

Critical Care(2022)10.1186/s13054-022-04204-9

N/A

2.1DataRank · unranked

94 citations

Bruno François, Marc Bourgeois, Apostolos Komnos, Ricard Ferrer, Galia Rahav +94 more

Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months

Journal of Clinical Investigation(2022)10.1172/jci160565

N/A

1.1DataRank · unranked

33 citations

Jill Maaske, Ann R. Falsey, Stephanie Sproule, Merlin L. Robb, Robert W. Frenck +18 more